Insmed | 운영 비용



Operating Expenses 변화 날짜
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Cytokinetics USD 155.97M 14.7M 2024-12
DBV Technologies USD 31.4M 3.6M 2024-09
Dynavax Technologies USD 73.66M 3.12M 2024-12
Gilead Sciences USD 4.43B 687M 2025-03
Insmed USD 334.86M 28M 2024-12
Novartis USD 10.15B 579M 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Insmed 운영 비용 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2025.